Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

6.6%

11 terminated/withdrawn out of 167 trials

Success Rate

89.3%

+2.8% vs industry average

Late-Stage Pipeline

8%

14 trials in Phase 3/4

Results Transparency

2%

2 of 92 completed trials have results

Key Signals

33 recruiting2 with results10 terminated

Enrollment Performance

Analytics

N/A
70(54.7%)
Phase 2
38(29.7%)
Phase 3
8(6.3%)
Phase 4
6(4.7%)
Phase 1
5(3.9%)
Early Phase 1
1(0.8%)
128Total
N/A(70)
Phase 2(38)
Phase 3(8)
Phase 4(6)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (167)

Showing 20 of 167 trials
NCT07552584Not ApplicableRecruiting

Blood Based Risk Evaluation With AI for Targeted Primary Health Care in Early Lung Cancer Detection

Role: lead

NCT06413641Not ApplicableActive Not Recruiting

VIsualization of Coronary Artery Disease for Modification of RISK Factors

Role: collaborator

NCT04223141Not ApplicableCompleted

Single-stapled Double Purse-string Technique for Colorectal Anastomosis

Role: lead

NCT07552636Not Yet Recruiting

Disease Activity Monitoring in Patients With Giant Cell Arteritis Study

Role: collaborator

NCT05776381Phase 2Not Yet Recruiting

The Impact of a Patient Decision Aid on Treatment Choices for Patients With an Unexpected Malignant Colorectal Polyp

Role: lead

NCT06473701Phase 3Recruiting

Reducing Breathlessness With Dronabinol in COPD Patients

Role: lead

NCT05972525Not ApplicableActive Not Recruiting

What Matters to Patients With Severe Hip or Knee Osteoarthritis?

Role: lead

NCT01918527Phase 3Active Not Recruiting

Neoadjuvant Chemotherapy Versus Standard Treatment in Patients With Locally Advanced Colon Cancer

Role: lead

NCT06647472Active Not Recruiting

Proteomic Analysis on Myopic Children Using Orthokeratology Lenses With Good or Poor Myopic Control

Role: lead

NCT07049822Enrolling By Invitation

Optimising Mammography Screening Accuracy With Blood-based Biomarkers

Role: lead

NCT07432802Not ApplicableNot Yet Recruiting

Sublobar Wedge Resection or Stereotactic Radiotherapy Treatment of High-risk Patients With Early-stage Lung Cancer

Role: collaborator

NCT07409844Phase 2Not Yet Recruiting

Neoadjuvant Immunotherapy and Organ-sparing Treatment in Patients With Stage I-III dMMR Colon Cancer

Role: collaborator

NCT06391554Not ApplicableRecruiting

Effects of EDUcation and EXercise Compared to Education Alone on Clinical and Physiological Outcomes in Patients With Hip Osteoarthritis

Role: collaborator

NCT04731025Phase 3Recruiting

Local Antibiotics for Breast Implants

Role: collaborator

NCT06015542Phase 2Recruiting

Self-administration of Subcutaneous Elranatamab in the Patients' Homes.

Role: collaborator

NCT05657054Not ApplicableActive Not Recruiting

Exercise Intervention Targeting Hip Strengthening Compared to Usual Care in Patients Undergoing Revision Hip Replacement

Role: collaborator

NCT07351721Not Yet Recruiting

Borrelia Arthritis - a Hidden Cause of Arthritis in Danish Patients?

Role: collaborator

NCT07347392Enrolling By Invitation

The Role of Radiotherapy for the Management of Non-melanoma Skin Cancer in Denmark.

Role: collaborator

NCT04095299Phase 3Recruiting

Standard Dose Versus High Dose of Radiotherapy in Rectal Preservation With Chemo-radiotherapy in Rectal Cancer Patients

Role: lead

NCT02438839Active Not Recruiting

Curative Chemoradiation of Low Rectal Cancer

Role: lead